Bharat Biotech plans Covaxin launch in second quarter of 2021, post requisite approvals Press Trust of India Nov 1, 2020 Immediate focus is to conduct Phase 3 trial successfully
Glenmark announces top-line results from Phase 3 clinical trial of favipiravir for COVID-19… EP News Bureau Jul 22, 2020 The study evaluated the efficacy and safety of favipiravir plus standard supportive care, versus standard supportive care alone,…
